| CENTER ID: | MytuD.18849.a |
| ORGANISM: | Mycobacterium tuberculosis H37Rv |
| ASSOCIATED DISEASE: | Tuberculosis |
| CURRENT STATUS: | purified |
| COMMUNITY REQUEST: | True |
| NIH RISK GROUP: | 2 |
| SELECT AGENT: | False |
| NIH PRIORITY pathogens category: |
IIIC |
| CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
|---|---|---|---|---|---|
| MytuD.18849.a.A1.GE44568 | full length | 1 | 886 | ||
| MytuD.18849.a.A2.GE44569 | LT truncation | 44 | 886 |
| CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
|---|---|---|---|---|---|
| MytuD.18849.a.A1.PW39188 | full length | 1 | 886 | ||
| MytuD.18849.a.A3.PW39219 | truncation #2 | 8 | 886 | ||
| MytuD.18849.a.A5.PW39220 | AlphaFold model | 11 | 886 |
| RESOURCE | REFERENCE ID |
|---|---|
| BV-BRC: | fig|83332.12.peg.2744 |
| TubercuList: | Rv2448c |
| MTB Network Portal: | Rv2448c |
| UniProt: | P9WFS9 |
| HARVESTED ON: | 11/11/2021 |
| SEQUENCED ON: | 11/11/2021 |
| EXPECTED MW: | 101kDa |
| OBSERVED MW: | 101kDa |
| ANTIBIOTIC MARKER: | ampicillin |
| COUNT OF EXPRESSION COLONIES: | Good (10-50) |
| TOTAL EXPRESSION LEVEL: | Moderate Expression |
| SOLUBLE EXPRESSION LEVEL | Moderate Expression |
| EXPRESSION HOST: | BL 21 (DE3) Rosetta |
| SEQUENCING RESULT: | |
| PERCENT IDENTITY: | 97 |
| PERCENT COVERAGE: | 68 |
| HARVESTED ON: | 11/11/2021 |
| SEQUENCED ON: | 11/11/2021 |
| EXPECTED MW: | 96kDa |
| OBSERVED MW: | 96kDa |
| ANTIBIOTIC MARKER: | ampicillin |
| COUNT OF EXPRESSION COLONIES: | Good (10-50) |
| TOTAL EXPRESSION LEVEL: | Low Expression |
| SOLUBLE EXPRESSION LEVEL | Insoluble |
| EXPRESSION HOST: | BL 21 (DE3) Rosetta |
| SEQUENCING RESULT: | |
| PERCENT IDENTITY: | 99 |
| PERCENT COVERAGE: | 67 |
| PURIFICATION DATe: | 1/20/2023 |
| CONCENTRATION: | 15.05mg/ml |
| OBSERVED MW: | 101kDa |
| EXPRESSION LEVEL: | Low Expression |
| PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
| EXPRESSION HOST: | BL 21 (DE3) Rosetta |
| VIAL COUNT (approx.): | 19 |
| VIAL VOLUME: | 110µl |
| PERCENT IDENTITY: | 97 |
| PERCENT COVERAGE: | 68 |
| PURIFICATION DATe: | 7/11/2023 |
| CONCENTRATION: | 16.3mg/ml |
| OBSERVED MW: | 100kDa |
| EXPRESSION LEVEL: | Low Expression |
| PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
| EXPRESSION HOST: | BL 21 (DE3) Rosetta |
| VIAL COUNT (approx.): | 1 |
| VIAL VOLUME: | 110µl |
| PERCENT IDENTITY: | data unavailable |
| PERCENT COVERAGE: | data unavailable |
| PURIFICATION DATe: | 7/11/2023 |
| CONCENTRATION: | 19.4mg/ml |
| OBSERVED MW: | 100kDa |
| EXPRESSION LEVEL: | Low Expression |
| PROTEIN PURIFICATION BUFFER: | 25 mM HEPES pH 7.0, 500 mM NaCl, 5% Glycerol, 2 mM DTT, 0.025% Azide |
| EXPRESSION HOST: | BL 21 (DE3) Rosetta |
| VIAL COUNT (approx.): | 2 |
| VIAL VOLUME: | 110µl |
| PERCENT IDENTITY: | data unavailable |
| PERCENT COVERAGE: | data unavailable |